Holen Sie sich die Stockscreener-App
87.38
2.43%
2.07
Handel nachbörslich:
87.38
Schlusskurs vom Vortag:
$85.31
Offen:
$85
24-Stunden-Volumen:
91,995
Relative Volume:
0.56
Marktkapitalisierung:
$1.98B
Einnahmen:
$213.03M
Nettoeinkommen (Verlust:
$41.32M
KGV:
47.75
EPS:
1.83
Netto-Cashflow:
$33.49M
1W Leistung:
+0.68%
1M Leistung:
-5.32%
6M Leistung:
+4.30%
1J Leistung:
-5.17%
1-Tages-Spanne:
$84.19
$87.67
1-Wochen-Bereich:
$84.19
$88.53
52-Wochen-Spanne:
$71.42
$109.58
Lemaitre Vascular Inc Stock (LMAT) Company Profile
Firmenname
Lemaitre Vascular Inc
Sektor
Telefon
781-221-2266
Adresse
63 SECOND AVENUE, BURLINGTON, MA
Vergleichen Sie LMAT mit anderen Aktien
| Aktien | Preis | Marktkapitalisierung | Umsatz | Nettogewinn | Free Cashflow | ENV |
|---|---|---|---|---|---|---|
LMAT
Lemaitre Vascular Inc
|
87.38 | 1.93B | 213.03M | 41.32M | 33.49M | 1.83 |
|
ISRG
Intuitive Surgical Inc
|
436.39 | 156.20B | 9.15B | 2.63B | 1.99B | 7.1661 |
|
BDX
Becton Dickinson Co
|
188.36 | 53.50B | 21.39B | 1.61B | 2.55B | 5.5609 |
|
RMD
Resmed Inc
|
270.07 | 39.84B | 5.15B | 1.40B | 1.65B | 9.5082 |
|
ALC
Alcon Inc
|
74.08 | 35.89B | 10.03B | 1.07B | 1.39B | 2.1549 |
|
WST
West Pharmaceutical Services Inc
|
261.17 | 18.87B | 2.96B | 487.70M | 344.00M | 6.6758 |
Lemaitre Vascular Inc Stock (LMAT) Upgrades & Downgrades
| Datum | Aktion | Analytiker | Ratingänderung |
|---|---|---|---|
| 2025-08-06 | Hochstufung | Barrington Research | Mkt Perform → Outperform |
| 2025-02-28 | Herabstufung | Barrington Research | Outperform → Mkt Perform |
| 2025-02-28 | Herabstufung | Oppenheimer | Outperform → Perform |
| 2025-02-13 | Eingeleitet | Wells Fargo | Equal Weight |
| 2024-10-15 | Eingeleitet | Cantor Fitzgerald | Neutral |
| 2024-08-02 | Fortgesetzt | Lake Street | Buy |
| 2024-05-31 | Fortgesetzt | ROTH MKM | Buy |
| 2024-04-26 | Hochstufung | Stifel | Hold → Buy |
| 2024-02-06 | Fortgesetzt | KeyBanc Capital Markets | Sector Weight |
| 2023-10-23 | Eingeleitet | JMP Securities | Mkt Outperform |
| 2023-09-06 | Eingeleitet | Oppenheimer | Outperform |
| 2023-08-03 | Herabstufung | Jefferies | Buy → Hold |
| 2023-05-03 | Hochstufung | Barrington Research | Mkt Perform → Outperform |
| 2022-10-28 | Herabstufung | Barrington Research | Outperform → Mkt Perform |
| 2021-09-16 | Eingeleitet | Jefferies | Buy |
| 2021-02-12 | Eingeleitet | KeyBanc Capital Markets | Sector Weight |
| 2020-03-16 | Hochstufung | Sidoti | Neutral → Buy |
| 2019-10-24 | Herabstufung | First Analysis Sec | Strong Buy → Outperform |
| 2019-10-24 | Hochstufung | Lake Street | Hold → Buy |
| 2019-10-14 | Hochstufung | First Analysis Sec | Outperform → Strong Buy |
| 2019-07-25 | Bestätigt | Barrington Research | Outperform |
| 2019-07-25 | Hochstufung | First Analysis Sec | Neutral → Outperform |
| 2018-10-08 | Hochstufung | Barrington Research | Mkt Perform → Outperform |
| 2018-10-08 | Hochstufung | ROTH Capital | Neutral → Buy |
| 2018-06-08 | Fortgesetzt | ROTH Capital | Buy |
| 2018-04-26 | Herabstufung | Stifel | Buy → Hold |
| 2018-04-26 | Hochstufung | The Benchmark Company | Hold → Buy |
| 2017-10-27 | Herabstufung | First Analysis Sec | Overweight → Equal-Weight |
| 2017-10-27 | Herabstufung | The Benchmark Company | Buy → Hold |
| 2017-07-10 | Herabstufung | Canaccord Genuity | Buy → Hold |
| 2017-07-10 | Herabstufung | The Benchmark Company | Buy → Hold |
| 2017-03-21 | Eingeleitet | First Analysis Sec | Overweight |
| 2017-02-22 | Herabstufung | Barrington Research | Outperform → Mkt Perform |
| 2016-09-22 | Herabstufung | Sidoti | Buy → Neutral |
| 2016-07-28 | Bestätigt | Barrington Research | Outperform |
| 2016-02-25 | Bestätigt | Barrington Research | Outperform |
Alle ansehen
Lemaitre Vascular Inc Aktie (LMAT) Neueste Nachrichten
Signal strength of LeMaitre Vascular Inc. stock in tech scanners2025 Volume Leaders & Free Real-Time Volume Trigger Notifications - newser.com
Best data tools to analyze LeMaitre Vascular Inc. stockPortfolio Performance Report & High Accuracy Buy Signal Tips - newser.com
Using data models to predict LeMaitre Vascular Inc. stock movementIndex Update & Risk Controlled Swing Trade Alerts - newser.com
How hedge fund analytics apply to LeMaitre Vascular Inc. stock2025 Retail Activity & Precise Swing Trade Entry Alerts - newser.com
When is the best time to exit LeMaitre Vascular Inc.Trade Signal Summary & Expert Approved Momentum Ideas - newser.com
Published on: 2025-10-12 21:02:34 - newser.com
Published on: 2025-10-12 10:19:29 - newser.com
How LeMaitre Vascular Inc. (LHU) stock reacts to Fed tighteningJuly 2025 EndofMonth & Intraday High Probability Alerts - newser.com
LeMaitre Vascular (LMAT): How a Strong Q2 and Raised Guidance Are Shaping Its Valuation Outlook - Sahm
LeMaitre Vascular (NASDAQ:LMAT) Earns Buy (B-) Rating from Weiss Ratings - MarketBeat
What technical models suggest about LeMaitre Vascular Inc.’s comeback2025 Valuation Update & Long-Term Growth Stock Strategies - newser.com
Is a relief rally coming for LeMaitre Vascular Inc. holdersJuly 2025 Action & Precise Swing Trade Entry Alerts - newser.com
LeMaitre Vascular, Inc. Announces Third Quarter 2025 Financial Results Release Date and Conference Call Details - Quiver Quantitative
LeMaitre Will Announce Third Quarter 2025 Earnings Results on November 6, 2025 - The Manila Times
Nov 6: LeMaitre Vascular to Announce Third-Quarter 2025 Results; Conference Call 5:00 PM EST - Stock Titan
What’s next for LeMaitre Vascular Inc. stock priceWeekly Gains Summary & Risk Managed Trade Strategies - newser.com
What MACD signals say about LeMaitre Vascular Inc.2025 Volume Leaders & AI Powered Trade Plan Recommendations - newser.com
Is now a turning point for LeMaitre Vascular Inc.2025 Support & Resistance & Free Technical Pattern Based Buy Signals - newser.com
Is LeMaitre Vascular Inc. forming a bottoming base2025 Big Picture & High Conviction Buy Zone Picks - newser.com
Detecting price anomalies in LeMaitre Vascular Inc. with AI2025 Trade Ideas & Fast Gain Stock Tips - newser.com
Is LeMaitre Vascular Inc LHU a good long term investmentBollinger Bands Signals & Access Free Tools and Start Investing - earlytimes.in
Financial Review: LeMaitre Vascular (NASDAQ:LMAT) and Ingen Technologies (OTCMKTS:IGNT) - Defense World
LeMaitre Vascular, Inc. (NASDAQ:LMAT) Receives $97.60 Consensus Price Target from Analysts - Defense World
Surgical Equipment & ConsumablesSpecialty Stocks Q2 Earnings Review: LeMaitre (NASDAQ:LMAT) Shines - Yahoo Finance
LeMaitre Vascular Inc. stock chart pattern explainedJuly 2025 News Drivers & Consistent Growth Stock Picks - newser.com
LeMaitre Vascular (LMAT): Unpacking Current Valuation After Steady Share Performance - Yahoo Finance
Smart tools for monitoring LeMaitre Vascular Inc.’s price actionWeekly Stock Report & Consistent Return Investment Signals - newser.com
State of Alaska Department of Revenue Boosts Stock Holdings in LeMaitre Vascular, Inc. $LMAT - Defense World
10,744 Shares in LeMaitre Vascular, Inc. $LMAT Purchased by Public Employees Retirement System of Ohio - Defense World
Analyzing LeMaitre Vascular Inc. with risk reward ratio chartsJuly 2025 Decliners & Community Consensus Picks - newser.com
Multi asset correlation models including LeMaitre Vascular Inc.2025 Major Catalysts & Smart Allocation Stock Tips - newser.com
LeMaitre Vascular, Inc. (NASDAQ:LMAT) Given Average Rating of "Moderate Buy" by Brokerages - MarketBeat
What MACD and RSI say about LeMaitre Vascular Inc.Quarterly Portfolio Report & Weekly Watchlist for Hot Stocks - newser.com
Copeland Capital Management LLC Sells 88,686 Shares of LeMaitre Vascular, Inc. $LMAT - MarketBeat
Using R and stats models for LeMaitre Vascular Inc. forecasting2025 Investor Takeaways & Smart Money Movement Tracker - newser.com
What drives LeMaitre Vascular Inc stock priceVWAP Trading Strategies & Build Diversified Portfolios With Ease - earlytimes.in
What analysts say about LeMaitre Vascular Inc stockMarket Sentiment Report & Superior Trading Ideas - earlytimes.in
Finanzdaten der Lemaitre Vascular Inc-Aktie (LMAT)
Umsatz
Nettogewinn
Free Cashflow
ENV
0.94%
0.50%
In Yahoo öffnen
|
In Google öffnen
|
In Finviz öffnen
|
In MarketWatch öffnen
|
Öffnen Sie in EDGAR
|
Offen in Reuters
Kapitalisierung:
|
Volumen (24h):